The treatment of<unk>  currently focuses on managing the pancreatic neuroendocrine tumors. Small tumors can be monitored but large ones need to be resected. As patients with<unk>  have life-long risk of developing pancreatic neuroendocrine tumors, they need to undergo periodic biochemical testing and imaging.
Mahvash disease
Dejerine–Sottas disease
Keshan disease
Yushō disease
Barakat syndrome
Satoyoshi syndrome
Sugarman syndrome
Nicolau–Balus syndrome